For the year ending 2025-12-31, SLNCF has $131,442K in assets. $69,138K in debts. $11,277K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 11,277 | |||
| Short-term investments | 73,837 | |||
| R&d benefit receivable | 22,007 | |||
| Other current assets | 11,537 | |||
| Trade receivables | 0 | |||
| Total current assets | 118,658 | |||
| Property, plant and equipment, net | 1,581 | |||
| Operating lease right-of-use asset | 167 | |||
| Goodwill | 10,621 | |||
| Intangible assets | 288 | |||
| Other long-term assets | 127 | |||
| Total assets | 131,442 | |||
| Contract liabilities | 168 | |||
| Trade and other payables | 13,356 | |||
| Operating lease liabilities, current | 89 | |||
| Total current liabilities | 13,613 | |||
| Contract liabilities | 55,454 | |||
| Operating lease liabilities, long-term | 71 | |||
| Total liabilities | 69,138 | |||
| Ordinary shares - par value &0.05 per share 141,701,848 shares issued at december 31, 2025 (2024 141,674,074) | 10,290 | |||
| Additional paid-in capital | 617,562 | |||
| Accumulated deficit | -562,572 | |||
| Accumulated other comprehensive loss | -2,976 | |||
| Total shareholders' equity | 62,304 | |||
| Total liabilities and shareholders' equity | 131,442 | |||
Silence Therapeutics plc (SLNCF)
Silence Therapeutics plc (SLNCF)